Relationship of serum iron and thyroid hormone in obesity and after laparoscopic sleeve gastrectomy.

IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Xingchun Wang, Yaling Fang, Xiu Huang, Lei Du, Hui Ren, Chunjun Sheng, Peng Yang, Yueye Huang, Shen Qu
{"title":"Relationship of serum iron and thyroid hormone in obesity and after laparoscopic sleeve gastrectomy.","authors":"Xingchun Wang, Yaling Fang, Xiu Huang, Lei Du, Hui Ren, Chunjun Sheng, Peng Yang, Yueye Huang, Shen Qu","doi":"10.1186/s12902-024-01753-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Iron is an essential element for thyroid function. However, no study focuses on the association between iron and thyroid in individuals with obesity. Our research aimed to investigate the iron status in relation to baseline thyroid hormone levels and after laparoscopic sleeve gastrectomy (LSG).</p><p><strong>Methods: </strong>A total of 216 subjects with obesity were enrolled and divided into low and high iron groups depending on the median value. The association between iron and thyroid hormone was analyzed and compared before and after LSG at the 6-month follow-up in patients who underwent LSG.</p><p><strong>Results: </strong>1) In all, Total Triiodothyronine (TT3) was significantly higher in high iron than low iron group (P = 0.008). TT3 and thyroid stimulating hormone (TSH) were significantly higher in high iron than low iron group (1.92 ± 0.61 vs. 1.69 ± 0.28 nmol/l, P = 0.029; 2.93 ± 1.66 vs. 1.88 ± 1.03 mU/l, P = 0.002) in females while not in males (all P > 0.05). 2) Iron was significantly positively associated with free triiodothyronine (FT3), free thyroxine (FT4), TT3 and TSH (all P < 0.05). Adjusted for body mass index (BMI), total cholesterol (TCH), high-density lipoprotein cholesterol (HDL-C), fasting insulin (FINS) and homeostatic model assessment of insulin resistance (HOMA-IR), FT3, FT4 and TSH were still significantly associated with iron (all P < 0.05). 3). Regression analysis showed that iron was significantly associated with FT4 (β = 0.338, P = 0.038). 3) LSG led to decreased FT3, FT3, TT3, total thyroxine (TT4) and TSH at 6 months follow-up (all P < 0.05). Changed FT4 was significantly associated with changed iron (r = 0.520, P = 0.009). Subjects with iron decreased had more significant decreased TT4 than subjects without iron decreased (P = 0.021).</p><p><strong>Conclusion: </strong>Serum iron overload is significantly associated with impaired thyroid function in subjects with obesity. LSG led to improved thyroid function which is associated with a change in iron.</p><p><strong>Trial registration: </strong>NCT04548232 registration date is on October 9, 2022, registered in https://register.</p><p><strong>Clinicaltrials: </strong>gov/ .</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"24 1","pages":"240"},"PeriodicalIF":2.8000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11542351/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Endocrine Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12902-024-01753-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Iron is an essential element for thyroid function. However, no study focuses on the association between iron and thyroid in individuals with obesity. Our research aimed to investigate the iron status in relation to baseline thyroid hormone levels and after laparoscopic sleeve gastrectomy (LSG).

Methods: A total of 216 subjects with obesity were enrolled and divided into low and high iron groups depending on the median value. The association between iron and thyroid hormone was analyzed and compared before and after LSG at the 6-month follow-up in patients who underwent LSG.

Results: 1) In all, Total Triiodothyronine (TT3) was significantly higher in high iron than low iron group (P = 0.008). TT3 and thyroid stimulating hormone (TSH) were significantly higher in high iron than low iron group (1.92 ± 0.61 vs. 1.69 ± 0.28 nmol/l, P = 0.029; 2.93 ± 1.66 vs. 1.88 ± 1.03 mU/l, P = 0.002) in females while not in males (all P > 0.05). 2) Iron was significantly positively associated with free triiodothyronine (FT3), free thyroxine (FT4), TT3 and TSH (all P < 0.05). Adjusted for body mass index (BMI), total cholesterol (TCH), high-density lipoprotein cholesterol (HDL-C), fasting insulin (FINS) and homeostatic model assessment of insulin resistance (HOMA-IR), FT3, FT4 and TSH were still significantly associated with iron (all P < 0.05). 3). Regression analysis showed that iron was significantly associated with FT4 (β = 0.338, P = 0.038). 3) LSG led to decreased FT3, FT3, TT3, total thyroxine (TT4) and TSH at 6 months follow-up (all P < 0.05). Changed FT4 was significantly associated with changed iron (r = 0.520, P = 0.009). Subjects with iron decreased had more significant decreased TT4 than subjects without iron decreased (P = 0.021).

Conclusion: Serum iron overload is significantly associated with impaired thyroid function in subjects with obesity. LSG led to improved thyroid function which is associated with a change in iron.

Trial registration: NCT04548232 registration date is on October 9, 2022, registered in https://register.

Clinicaltrials: gov/ .

肥胖症和腹腔镜袖带胃切除术后血清铁和甲状腺激素的关系。
背景:铁是甲状腺功能所必需的元素。然而,还没有研究关注肥胖症患者体内铁与甲状腺之间的关系。我们的研究旨在调查铁的状态与基线甲状腺激素水平以及腹腔镜袖带胃切除术(LSG)后的关系:方法:我们共招募了 216 名肥胖症患者,并根据中位值将其分为低铁组和高铁组。方法:共招募了 216 名肥胖症患者,根据中位值将其分为低铁组和高铁组,并在 6 个月的随访中分析和比较了 LSG 前后铁与甲状腺激素之间的关系:1)总三碘甲状腺原氨酸(TT3)在高铁组明显高于低铁组(P = 0.008)。高铁组女性的总三碘甲状腺原氨酸(TT3)和促甲状腺激素(TSH)明显高于低铁组(1.92 ± 0.61 vs. 1.69 ± 0.28 nmol/l,P = 0.029;2.93 ± 1.66 vs. 1.88 ± 1.03 mU/l,P = 0.002),而男性则没有差异(均 P > 0.05)。2)铁与游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、TT3 和促甲状腺激素呈明显正相关(均为 P 结论:血清铁超载与肥胖症患者甲状腺功能受损密切相关。LSG可改善甲状腺功能,而甲状腺功能的改善与铁的变化有关:NCT04548232注册日期为2022年10月9日,注册网址为https://register.Clinicaltrials: gov/ .
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Endocrine Disorders
BMC Endocrine Disorders ENDOCRINOLOGY & METABOLISM-
CiteScore
4.40
自引率
0.00%
发文量
280
审稿时长
>12 weeks
期刊介绍: BMC Endocrine Disorders is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of endocrine disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信